A Study of IBI362 in Participants With Type 2 Diabetes

Clinical trial NCT05606913 · COMPLETED

Trial details

NCT number: NCT05606913
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2023-01-06
Primary completion: 2024-01-26
Enrollment: 731

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.